• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    31.70 Up 0.12(0.38%) Jan 23, 4:00PM EST
    |After Hours : 31.70 0.00 (0.00%) Jan 23, 4:31PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 2,919   53,140   77,413  
    Cost of Revenue -   -   -  
    Gross Profit 2,919   53,140   77,413  
    Operating Expenses
    Research Development39,248  37,163  30,951  
    Selling General and Administrative13,349  14,529  12,540  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (49,678) 1,448   33,922  
    Income from Continuing Operations
    Total Other Income/Expenses Net3,588  3,577  3,649  
    Earnings Before Interest And Taxes(46,090)5,025  37,571  
    Interest Expense -   -   -  
    Income Before Tax(46,090)5,025  37,571  
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(46,090)5,025  37,571  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (46,090) 5,025   37,571  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (46,090) 5,025   37,571  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.